Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

IDBE

ID Biomedical (IDBE)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IDBE
DataOraFonteTitoloSimboloCompagnia
08/12/200516:00PR Newswire (US)ID Biomedical announces closing of acquisition by GlaxoSmithKlineNASDAQ:IDBE
07/12/200502:40PR Newswire (US)ID Biomedical announces receipt of court approval for acquisition by GlaxoSmithKlineNASDAQ:IDBE
05/12/200515:15PR Newswire (US)ID Biomedical provides update on application for court approval of acquisition by GlaxoSmithKlineNASDAQ:IDBE
18/11/200523:06PR Newswire (US)ID Biomedical announces rescheduling of court hearing to approve acquisition by GlaxoSmithKlineNASDAQ:IDBE
16/11/200523:28PR Newswire (US)ID Biomedical announces results of securityholders' votes relating to acquisition by GlaxoSmithKlineNASDAQ:IDBE
10/11/200516:28PR Newswire (US)ID Biomedical reports 2005 third quarter resultsNASDAQ:IDBE
24/10/200516:40PR Newswire (US)ID Biomedical Provides Update on Vaccine Development ProgramsNASDAQ:IDBE
21/10/200501:54PR Newswire (US)ID Biomedical announces mailing of meeting materialsNASDAQ:IDBE
07/09/200518:06PR Newswire (US)GlaxoSmithKline To Acquire ID Biomedical CorporationNASDAQ:IDBE
15/08/200523:00PR Newswire (US)ID Biomedical reports 2005 second quarter resultsNASDAQ:IDBE
10/08/200521:10PR Newswire (US)ID Biomedical announces 2005 second quarter release date and conference callNASDAQ:IDBE
12/07/200516:00PR Newswire (US)ID Biomedical's flu vaccine granted Fast Track status by FDANASDAQ:IDBE
26/05/200516:30PR Newswire (US)ID Biomedical announces webcast of 2005 Annual General Meeting of ShareholdersNASDAQ:IDBE
16/05/200523:00PR Newswire (US)ID Biomedical reports 2005 first quarter resultsNASDAQ:IDBE
11/05/200516:30PR Newswire (US)ID Biomedical announces 2005 first quarter release date and conference callNASDAQ:IDBE
30/03/200517:42PR Newswire (US)ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral Clinical Trial in the U.S.NASDAQ:IDBE
22/03/200516:04PR Newswire (US)ID Biomedical receives positive data from clinical testing of its Group-Common Pneumococcal VaccineNASDAQ:IDBE
16/03/200522:01PR Newswire (US)ID Biomedical reports fiscal 2004 year end resultsNASDAQ:IDBE
15/03/200515:30PR Newswire (US)ID Biomedical to pursue U.S. accelerated approval process for its influenza vaccineNASDAQ:IDBE
14/03/200516:40PR Newswire (US)ID Biomedical announces 2004 year end earnings release date and conference callNASDAQ:IDBE
04/03/200515:30PR Newswire (US)ID Biomedical closes sale and leaseback transactionsNASDAQ:IDBE
26/01/200515:15PR Newswire (US)ID Biomedical Announces Immunogenicity Results from Phase II Trial of StreptavaxNASDAQ:IDBE
19/01/200515:15PR Newswire (US)ID Biomedical begins development of pandemic influenza vaccineNASDAQ:IDBE
13/01/200517:34PR Newswire (US)ID Biomedical announces final results from field efficacy trial of its intranasal flu vaccineNASDAQ:IDBE
10/01/200517:16PR Newswire (US)ID Biomedical announces the beginning of a U.S. phase I clinical trial for plague vaccine candidateNASDAQ:IDBE
10/01/200515:15PR Newswire (US)ID Biomedical Closes Financing TransactionNASDAQ:IDBE
10/01/200515:01PR Newswire (US)CSC's DVC Enters Clinical Trial for Plague Vaccine CandidateNASDAQ:IDBEID Biomedical - Common Shares (MM)
07/01/200515:15PR Newswire (US)ID Biomedical receives clearance for Fluviral clinical testing in the U.S.NASDAQ:IDBE
04/01/200515:15PR Newswire (US)ID Biomedical Announces Sale and Leaseback TransactionsNASDAQ:IDBE
22/12/200415:15PR Newswire (US)ID Biomedical to repurchase Shire subscription receiptsNASDAQ:IDBE
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IDBE
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network